Hester Biosciences Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Hester Biosciences Stock Forecast and Price Target
Hester Biosciences's stock is projected to advance by -63.5% from the previous closing price if it reaches the average target of Rp600.96 by the year's end, as reputable analysts recently projected. This potential downside is calculated on a high-end estimate of Rp673.07 and a low-end estimate of Rp534.85. If interested in 524669 stock, you may also want to consider its competitors.
-63.50% Downside
Hester Biosciences Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Hester Biosciences's Price has decreased from Rp981.15 to Rp0.00 – a 100.00% drop! For next year, analysts predict Fair Value of Rp1201.92, which would mean an increase of 100.00%. Over the next six years, experts predict that Hester Biosciences's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIOCON Stock Forecast | Biocon | Hold |
14
|
Rp298.55 | Buy/Sell | Rp270.86 | -11.24% |
| 524348 Stock Forecast | Aarti Drugs | Outperform |
16
|
Rp504.55 | Buy/Sell | Rp612.50 | 11.39% |
| PANACEABIO Stock Forecast | Panacea Biotec | - |
7
|
Rp165.55 | Buy/Sell | Rp0.00 | -100.00% |
| BETA Stock Forecast | Beta Drugs | - |
0
|
Rp1.43k | Buy/Sell | Rp0.00 | -100.00% |
| 532039 Stock Forecast | Zenotech Laboratories | - |
0
|
Rp68.64 | Buy/Sell | Rp0.00 | -100.00% |
Hester Biosciences Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Hester Biosciences's Revenue has grown by 48.17%, rising from Rp1.88B to Rp2.78B. The next year, 0 experts forecast that Hester Biosciences's Revenue will decrease by 12.28%, reaching Rp2.44B. In 2030, professionals predict that Hester Biosciences's Revenue will decrease by 12.16%, reaching Rp2.44B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 524717 Stock Forecast | Titan Biotech | - |
0
|
Rp502.00 | Buy/Sell | Rp0.00 | -100.00% |
| 524663 Stock Forecast | Bharat Immunologicals & Biolog... | - |
0
|
Rp34.98 | Buy/Sell | Rp0.00 | -100.00% |
| 526139 Stock Forecast | Transgene Biotek | - |
0
|
Rp11.87 | Buy/Sell | Rp0.00 | -100.00% |
.jpg)
Hester Biosciences Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Hester Biosciences's Dividend per Share has grown by 21.21%, rising from Rp6.60 to Rp8.00. According to the 0 analysts polled, in the next year, Hester Biosciences's Dividend per Share will fall by 3.00%, reaching Rp7.76. Over the next seven years, experts predict that Hester Biosciences's Dividend per Share will grow at a rate of 7.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 532041 Stock Forecast | Hindustan Bio Sciences | - |
0
|
Rp8.73 | Buy/Sell | Rp0.00 | -100.00% |
| 514336 Stock Forecast | Genesis IBRC India | - |
0
|
13.06 | Buy/Sell | 0.00 | -100.00% |
| 532871 Stock Forecast | Celestial Biolabs | - |
0
|
0.00 | Buy/Sell | 0.00 | 0.00% |
Hester Biosciences EBITDA Forecast for 2023 - 2025 - 2030
Hester Biosciences's EBITDA has grown In the last three years, rising from Rp604.03M to Rp624.22M – a growth of 3.34%. According to 0 prominent analysts, Hester Biosciences's EBITDA will fall by 0.30% in the next year, reaching Rp622.35M. For the next seven years, experts predict that Hester Biosciences's EBITDA will grow at a rate of 5.41%.
Hester Biosciences EBIT Forecast for 2023 - 2025 - 2030
Hester Biosciences's EBIT has decreased In the last three years, from Rp472.26M to Rp420.28M – a 11.01% drop. In the next year, analysts believe that EBIT will reach Rp445.86M – an increase of 6.09%. For the next seven years, the forecast is for EBIT to grow by 17.40%.
Hester Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Hester Biosciences's EPS has decreased from Rp43.51 to Rp0.00 – a 100.00% drop! For next year, analysts predict EPS of Rp53.30, which would mean an increase of 100.00%. Over the next six years, experts predict that Hester Biosciences's EPS will grow at a rate of 100.00%.
.jpg)